Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1967 1
1968 5
1969 4
1970 3
1971 4
1972 6
1973 8
1974 12
1975 12
1976 9
1977 6
1978 12
1979 7
1980 18
1981 14
1982 13
1983 22
1984 33
1985 17
1986 20
1987 43
1988 70
1989 80
1990 65
1991 91
1992 99
1993 104
1994 104
1995 90
1996 125
1997 139
1998 126
1999 105
2000 158
2001 175
2002 151
2003 198
2004 155
2005 144
2006 152
2007 165
2008 156
2009 141
2010 179
2011 180
2012 187
2013 154
2014 172
2015 165
2016 159
2017 138
2018 141
2019 145
2020 163
2021 147
2022 141
2023 116
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

4,950 results

Results by year

Filters applied: . Clear all
Page 1
Overview of prostate anatomy, histology, and pathology.
Lee CH, Akin-Olugbade O, Kirschenbaum A. Lee CH, et al. Endocrinol Metab Clin North Am. 2011 Sep;40(3):565-75, viii-ix. doi: 10.1016/j.ecl.2011.05.012. Endocrinol Metab Clin North Am. 2011. PMID: 21889721 Review.
The human prostate is heterogeneous with regard to its embryologic origin. The two most prevalent diseases of aging males, benign prostatic hyperplasia and prostate cancer (PCa), arise from different zones within the prostate. The biology of PCa is als …
The human prostate is heterogeneous with regard to its embryologic origin. The two most prevalent diseases of aging males, benign …
Prostate Pathology: What is New in the 2022 WHO Classification of Urinary and Male Genital Tumors?
Surintrspanont J, Zhou M. Surintrspanont J, et al. Pathologica. 2022 Feb;115(1):41-56. doi: 10.32074/1591-951X-822. Epub 2023 Jan 16. Pathologica. 2022. PMID: 36645399 Free PMC article. Review.
Although no major alterations were made to this chapter, some of the most notable updates include restructure of contents and introduction of a new format; standardization of mitotic counts, genomic nomenclatures, and units of length; refined definition for the terms "variant", " …
Although no major alterations were made to this chapter, some of the most notable updates include restructure of contents and introduction o …
Intraductal carcinoma of the prostate: a comprehensive and updated review.
Tsuzuki T. Tsuzuki T. Int J Urol. 2015 Feb;22(2):140-5. doi: 10.1111/iju.12657. Epub 2014 Oct 31. Int J Urol. 2015. PMID: 25358604 Review.
Intraductal carcinoma of the prostate is characterized by prostatic carcinoma cells growing within ducts and/or acini. ...Although the Gleason score does not consider intraductal carcinoma of the prostate, some cribriform prostate …
Intraductal carcinoma of the prostate is characterized by prostatic carcinoma cells growing within ducts and/or …
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications.
Tariq A, McCart Reed AE, Morton A, Porten S, Vela I, Williams ED, Yaxley JW, Black PC, Roberts MJ. Tariq A, et al. Eur Urol Focus. 2022 Sep;8(5):1256-1269. doi: 10.1016/j.euf.2021.07.016. Epub 2021 Aug 21. Eur Urol Focus. 2022. PMID: 34429271 Review.
CONTEXT: Staging, restaging, and surveillance of urothelial carcinoma (UC) is challenging due to suboptimal accuracy of standard of care imaging modalities. Prostate-specific membrane antigen (PSMA) imaging may serve to improve characterisation of UC. ...
CONTEXT: Staging, restaging, and surveillance of urothelial carcinoma (UC) is challenging due to suboptimal accuracy of standard of c …
Cribriform Lesions of the Prostate Gland.
Cai Q, Shah RB. Cai Q, et al. Surg Pathol Clin. 2022 Dec;15(4):591-608. doi: 10.1016/j.path.2022.07.001. Epub 2022 Oct 13. Surg Pathol Clin. 2022. PMID: 36344177 Review.
"Cribriform lesions of the prostate represent an important and often diagnostically challenging spectrum of prostate pathology. These lesions range from normal anatomical variation, benign proliferative lesions, premalignant, suspicious to frankly malignant and biol …
"Cribriform lesions of the prostate represent an important and often diagnostically challenging spectrum of prostate pathology …
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.
Zong Y, Montironi R, Massari F, Jiang Z, Lopez-Beltran A, Wheeler TM, Scarpelli M, Santoni M, Cimadamore A, Cheng L. Zong Y, et al. Eur Urol Focus. 2021 Sep;7(5):955-963. doi: 10.1016/j.euf.2020.10.007. Epub 2020 Oct 31. Eur Urol Focus. 2021. PMID: 33132109 Review.
Intraductal carcinoma of the prostate (IDC-P), a clinicopathological entity characterized by malignant prostatic epithelial cells growing within ducts and/or acini, has a distinct architectural pattern, cytological features, and biological behavior. ...Furthe …
Intraductal carcinoma of the prostate (IDC-P), a clinicopathological entity characterized by malignant prostatic epithe …
Renal-type clear cell carcinoma of prostate: A case report and review of literature.
Liao G, Zhang X, Li Z, Lan S, Huang M, Huang W. Liao G, et al. Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):431-433. doi: 10.4103/IJPM.IJPM_396_17. Indian J Pathol Microbiol. 2018. PMID: 30004074 Free article. Review.
We analyzed the clinicopathological features of renal-type clear cell carcinoma (RTCCC) in the prostate and its diagnosis according to the example in our hospital and review of the literature. ...This tumor is a rare variant of the prostate carcinomas. …
We analyzed the clinicopathological features of renal-type clear cell carcinoma (RTCCC) in the prostate and its diagnosis acco …
Intraductal carcinoma of the prostate: What we know and what we do not know.
Chen X, Ding B, Zhang P, Geng S, Xu J, Han B. Chen X, et al. Pathol Res Pract. 2018 May;214(5):612-618. doi: 10.1016/j.prp.2018.03.003. Epub 2018 Mar 6. Pathol Res Pract. 2018. PMID: 29628124 Review.
Intraductal carcinoma of the prostate (IDC-P) is a malignant, clonal proliferation of cells growing within the basement membrane-bound structures of the prostate. IDC-P is usually associated with unfavorable clinicopathologic parameters such as large tumor vo …
Intraductal carcinoma of the prostate (IDC-P) is a malignant, clonal proliferation of cells growing within the basement membra …
Benign mimics of prostatic adenocarcinoma.
Trpkov K. Trpkov K. Mod Pathol. 2018 Jan;31(S1):S22-46. doi: 10.1038/modpathol.2017.136. Mod Pathol. 2018. PMID: 29297489 Free article. Review.
Various benign mimics of prostatic carcinoma may be also evaluated based on their morphologic similarity to Gleason patterns 3-5 of prostatic adenocarcinoma. ...Therefore, before signing out a report with a diagnosis of prostatic carcinoma, path …
Various benign mimics of prostatic carcinoma may be also evaluated based on their morphologic similarity to Gleason patterns 3 …
Neuroendocrine tumors of the prostate.
Fine SW. Fine SW. Mod Pathol. 2018 Jan;31(S1):S122-132. doi: 10.1038/modpathol.2017.164. Mod Pathol. 2018. PMID: 29297494 Free article. Review.
Neuroendocrine (NE) differentiation in tumors of the prostate or in the setting of prostate cancer (PCa) is rare. A survey of these lesions is presented, including usual PCa with focal NE marker-positive cells, Paneth cell-like change, prostatic 'carcinoid', …
Neuroendocrine (NE) differentiation in tumors of the prostate or in the setting of prostate cancer (PCa) is rare. A survey of …
4,950 results